Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...
Morningstar3d
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
safety issues resulting from the administration of Regeneron’s Products and Regeneron’s Product Candidates (such as linvoseltamab) in patients, including serious complications or side effects ...
manilatimes3d
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
safety issues resulting from the administration of Regeneron's Products and Regeneron's Product Candidates (such as linvoseltamab) in patients, including serious complications or side effects in ...
Regeneron Pharmaceuticals, Inc.: Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
pharmaphorum2d
Regeneron bids to join the BCMA bispecific camp
are associated with higher rates of side effects, such as cytokine release syndrome (CRS), and tend to need longer stays in hospital. On safety, linvoseltamab had a 100% adverse event rate ...
pharmaphorum2d
GSK scores again with Blenrep in multiple myeloma
The jury is out on that, however, in part because the drug has been associated with side effects, particularly ... and other drugs like Regeneron’s linvoseltamab are all being tested in pivotal ...
Nasdaq3d
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...
Regeneron Gets CHMP Backing of Linvoseltamab in Multiple Myeloma
Regeneron on Friday said the recommendation covers adults with adults with relapsed and refractory multiple myeloma who have received at least three prior therapies, including a proteasome inhibitor, ...
Parade on MSN5d
The Scary Ozempic Side Effect No One's Talking About—and What You Can Do
Ozempic is often hailed as a wonder drug, but like any other medication, it’s not perfect. People have reported mild side ...
Variety6d
Charlamagne Tha God, iHeartMedia Announce 2025 Black Effect Podcast Festival Lineup
Radio host, podcaster and entrepreneur Charlamagne Tha God and iHeartMedia announced the third annual Black Effect Podcast Festival, including featured speakers at the event aimed at aspiring ...
AZFamily3d
On Your Side
Two Phoenix travelers' confusion over a cruise line's charges leads to On Your Side stepping in and sorting the matter out. A Mesa woman some expensive and fragile pieces of equipment and was ...